Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
MATSUI CONSTRUCTION CO., LTD.	1810	Japan Exchange	33,908	817 JPY	Stock
MATSUI SECURITIES CO., LTD.	8628	Japan Exchange +3 Other	607,842	809 JPY	Stock
MATSUI SECURITIES CO., LTD.	MTSEF	OTC Markets	-	9.5 USD
MATSUI SECURITIES CO., LTD.	MTW	Deutsche Boerse AG	-	4.72 EUR
MATSUI SECURITIES CO., LTD.	MTW	BOERSE MUENCHEN	-	4.76 EUR
MATSUI SECURITIES CO., LTD.	MAUSY	OTC Markets	335	10.6 USD	Stock

News (28)

ARTELO BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-07-12	AQ
HALOZYME THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-05-06	AQ
Artelo Biosciences : Annual Transition Report (Form 10-KT)	22-03-21	PU
Sutro Biopharma Announces Appointment of Heidi Hunter to Board of Directors	21-11-17	PR
ARTELO BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)	21-07-26	AQ
Artelo Biosciences, Inc. Announces Board Changes	21-07-26	CI
ARTELO BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	21-07-20	AQ
Transcript : Sutro Biopharma, Inc. - Shareholder/Analyst Call	21-06-03
Sutro Biopharma : Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer	21-04-20	PR
Artelo Biosciences : Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors	21-03-09	AQ
Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors	20-12-02	GL
Sutro Biopharma : Announces Appointment of Jon M. Wigginton, M.D., to Board of Directors	20-12-01	PR
ARTELO BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	20-06-22	AQ
SUTRO BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	20-06-05	AQ
Transcript : Sutro Biopharma, Inc. - Shareholder/Analyst Call	20-06-05
Sutro Biopharma : Securities offered to employees pursuant to employee benefit plans	20-03-16	PU
Artelo Biosciences : 10-K/A Filing	19-12-18	PU
Artelo Biosciences : Announces Appointment of Seasoned Finance and Industry Executive John W. Beck to Board of Directors	19-12-11	AQ
Artelo Biosciences Announces Appointment of Seasoned Finance and Industry Executive John W. Beck to Board of Directors	19-12-09	GL
Sutro Biopharma, Inc. Announces Board Changes	19-06-24	CI
Sutro Biopharma : Appoints Biopharma Veteran Connie Matsui as Board Chair	19-06-24	PR
Outdoor Foundation Invests $1.8 Million Into Four Thrive Outside Communities	19-04-15	PR
Alliance Healthcare Foundation : Announces $2M Innovation Initiative Funding & Establishes New Innovation Fund at The San Diego Foundation	18-09-12	PR
Halozyme Therapeutics : President And Chief Executive Officer, Dr. Helen Torley Named EY Entrepreneur Of The Year 2018 San Diego	18-06-11	PR
Halozyme Therapeutics : Announces Nomination Of Directors For Reelection At 2018 Stockholder Meeting	18-03-22	PR
Association of Gaming Equipment Manufacturers (AGEM) Announces Contract Extensions for Executive Director and Director of Responsible Gaming as Membership Total Hits 168 Companies	18-02-14	GL
Artelo Biosciences, Inc. Announces Board Appointments	17-05-08	CI
Association of Gaming Equipment Manufacturers (AGEM) Announces Appointment of Connie Jones as AGEM Director of Responsible Gaming	14-01-09	MW

Companies (3)

MATSUI SECURITIES CO., LTD. 1 335 M $

MATSUI SECURITIES CO., LTD. is a Japan-based securities company engaged in financial product trading business. The Company conducts stock brokering and underwriting operations through Internet transactions. The Company mainly conducts stock brokering busi ...

MATSUI CONSTRUCTION CO., LTD. 153 M $

MATSUI CONSTRUCTION CO., LTD. is a Japan-based company mainly engaged in the construction work, real estate business and sales of building materials. The Company operates through two business segments. The Construction segment is involved in the construct ...

MATSUI SECURITIES CO., LTD. 1 335 M $

Insiders

Connie Matsui

Ms. Connie L. Matsui is a Chairman at Sutro Biopharma, Inc., a Chairman at Artelo Biosciences, Inc., a Chairman at Halozyme Therapeutics, Inc. and a Chairman at Balboa Park Conservancy. Ms. Matsui was previously employed as a National President by Girl Scouts of the USA, an Executive Vice President by Biogen Idec New Ventures, Inc., a Senior Vice President by IDEC Pharmaceuticals Corp., an Executive VP-Knowledge & Innovation Networks by Biogen Idec, Inc., and a President & Chief Executive Officer by The San Diego Foundation. She received her undergraduate degree from Stanford University and an MBA from Stanford University.

Takeshi Matsui

Takeshi Matsui is currently a Director at Everystar Co., Ltd.
He previously worked at DeNA Co., Ltd.
as an Executive Officer & GM-Open Platform Business.

Takashi Matsui

Tsuneyoshi Matsui

Tsuneyoshi Matsui is an Independent Outside Director at KISOJI CO., LTD.
since 2015.
He was the President & Representative Director at Toho Gas Living Co. Ltd.
from 2006 to 2016.
He also held the position of Senior Managing Executive Officer at TOHO GAS Co., Ltd.

Kuniyoshi Matsui

Toshiaki Matsui

Ryoju Matsui

Ryoju Matsui currently works at Itochu Kenzai Corp., as Director.

Hiroshi Matsui

Hideki Matsui

Kenji Matsui

Kenji Matsui is currently the Chairman at Adjuvant Hong Kong Co. Ltd.
He previously worked as the Managing Director at Adjuvant Holdings Co., Ltd.
in 2016.
He also held a position as Director at Innovation Academy KK.

No results for this search